YUSMILOS Trademark

Trademark Overview


On Monday, September 3, 2018, a trademark application was filed for YUSMILOS with the United States Patent and Trademark Office. The USPTO has given the YUSMILOS trademark a serial number of 79249191. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 5, 2025. This trademark is owned by TAIHO PHARMACEUTICAL CO., LTD.. The YUSMILOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoim...
yusmilos

General Information


Serial Number79249191
Word MarkYUSMILOS
Filing DateMonday, September 3, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 5, 2025
Registration Number5754139
Registration DateTuesday, May 21, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 5, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, January 10, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, January 14, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, January 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 15, 2019ASSIGNED TO EXAMINER
Saturday, January 19, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, January 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 13, 2019NOTICE OF PUBLICATION
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Friday, March 22, 2019CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, May 21, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, June 20, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, June 26, 2019CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Wednesday, June 26, 2019FINAL DISPOSITION PROCESSED
Wednesday, June 26, 2019FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 18, 2019NOTIFICATION PROCESSED BY IB
Friday, July 4, 2025CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, September 23, 2025CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, December 5, 2025CANCELLED SECTION 71